Jump to content

Tarceva and a media opportunity


Jyoung20

Recommended Posts

As you may know, I just got home from a trip to New York. It was a press conference presented by Genentech, the maker of Tarceva. I just received a request from one of the directors. She asked if I knew any other survivors currently taking Tarceva. I told her about this site and she wanted me to ask if any of you that are currently taking Tarceva would be interested in being contacted by the media in your area. I told her I would let you know. If this is something you are interested in, you can pm me or e-mail me and I will forward it to her.

I know that my trip was an opportunity to bring awareness to a number of journalists from various magazines.

GOD BLESS!!

Jamie

Link to comment
Share on other sites

Here is the note about the media opportunities.

I wanted to get your thoughts on whether you feel like any of these folks would be interested in working with us in their local areas to possibly do media outreach (of course provided their physician would be willing to speak along with them.

If you are doing well on Tarceva this could be an opportunity to spread the word to others who may not know about the drug. I realize this is also a great benefit to the drug company but I keep thinking of where I might be without them. Needless to say, an opportunity to promote awareness in your area about lung cancer.

No pressure---just wanted to let you know this opportunity exists.

GOD BLESS!!

Jamie

Link to comment
Share on other sites

  • 3 months later...

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.